Repozytorium

Autor publikacji V. J. Hruby

1999
1999

The effect of halogenation on blood-brain barrier permeability of a novel peptide drug.

Gentry C. L., Egleton R. D., Gillespie T. J., Abbruscato H. B, Bartosz-Bechowski Hubert, Hruby V. J., Davis T. P.

1998

Consequences of cis-amide bond simulation in opioid peptides.

Olczak J., Kaczmarek K., Maszczyńska I., Lisowski Marek, Stropova D., Hruby V. J., Yamamura H. I., Lipkowski A. W., Zabrocki Janusz

1997

Cyclic enkephalin analogues with exceptional potency and selectivity for δ-opioid receptors.

Hruby V. J., Bartosz-Bechowski Hubert, Davis P., Slaninova J., Zalewska T., Stropova D., Porreca F., Yamamura H. I.

1997

Extraordinary potency of a novel delta opioid receptor agonist is due in part to increased efficacy.

Kramer T. H., Bartosz-Bechowski Hubert, Davis P., Hruby V. J., Porreca F.

1996

Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability.

Greene D. L., Hau V. S., Abbruscato T. J., Bartosz-Bechowski Hubert, Misicka A., Lipkowski A. W., Hom S., Gillespie T. J., Hruby V. J., Davis T. P.

1994

Cyclic enkephalin analogs with exceptional potency at peripheral δ opioid receptors.

Bartosz-Bechowski Hubert, Davis P., Zalewska T., Slaninova J., Porreca F., Yamamura H. I., Hruby V. J.

1993

Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs.

Weber S. J., Abbruscato T. J., Brownson E. A., Lipkowski A. W., Polt R., Misicka A., Haaseth R. C., Bartosz-Bechowski Hubert, Hruby V. J., Davis T. P.